OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP) Files An 8-K Other EventsItem 8.01. Other Events.
The Registrant has determined to evaluate the potential benefits of cross listing its shares of common stock, currently subject to quotation on the OTCQB: OWCP, for listing on a Canadian stock exchange, such as the Toronto Stock Exchange, among others. We believe that cross listing may improve the Registrant’s access to capital and liquidity. To this end, the Registrant has agreed to engage a major national Canadian law firm with specific expertise in venture capital markets to assist us in achieving a listing on a Canadian exchange.
About OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP)
OWC Pharmaceutical Research Corp. is a medical cannabis research and development company. The Company is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The Company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. As of September 30, 2016, the Company was engaged in two business activities: work with GUMI to commercialize and market the Company’s Electromagnetic Percussion Device (the Device), and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD) migraines and a delivery system.
